Patents matching “ONC”

US 10039827

Reoviruses having modified sequences

ONCOLYTICS BIOTECH INC. · Granted Aug 7, 2018 · Expires Aug 2, 2038

US 10035832

HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

US 10022364

Methods of treating cancer patients with farnesyltransferase inhibitors

Kura Oncology, Inc. · Granted Jul 17, 2018 · Expires Jul 12, 2038

US 2018169113

HIGH CONCENTRATION FORMULATION

CASSIOPEA S P A [IT] · Granted Jun 21, 2018 · Expires Jun 16, 2038

US 9969777

Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV)

The Pirbright Institute · Granted May 15, 2018 · Expires May 10, 2038

US 9962390

Mosapride sustained-release formulation providing pharmacological and clinical effects with once-daily administration

KOREA UNITED PHARM. INC. · Granted May 8, 2018 · Expires May 3, 2038

US 9956215

Methods of treating cancer with farnesyltransferase inhibitors

Kura Oncology, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

US 9951078

Inhibitors of ERK and methods of use

Kura Oncology, Inc. · Granted Apr 24, 2018 · Expires Apr 19, 2038

US 9896664

Oncolytic rhabdovirus

TURNSTONE LIMITED PARTNERSHIP · Granted Feb 20, 2018 · Expires Feb 15, 2038

US 9849167

Compositions and methods for combination therapy with dengue virus and dendritic cells

PrimeVax Immuno-Oncology · Granted Dec 26, 2017 · Expires Dec 21, 2037

US 9850323

High concentration chitosan-nucleic acid polyplex compositions

ENGENE, INC. · Granted Dec 26, 2017 · Expires Dec 21, 2037

US 9738721

Oncostatin M receptor antigen binding proteins

Kiniksa Pharmaceuticals, GmbH · Granted Aug 22, 2017 · Expires Aug 17, 2037

US 9730989

Compositions and methods for combination therapy with dengue virus and dendritic cells

PrimeVax Immuno-Oncology · Granted Aug 15, 2017 · Expires Aug 10, 2037

US 9707221

Methods of treating cancer patients with farnesyltransferase inhibitors

Kura Oncology, Inc. · Granted Jul 18, 2017 · Expires Jul 13, 2037

US 9701946

Purification method for embryo—derived infectious bronchitis virus (IBV)

SOUTH CHINA AGRICULTURAL UNIVERSITY · Granted Jul 11, 2017 · Expires Jul 6, 2037

US 9689042

Use of glycolytic pathways for inhibiting or measuring oncogenic signaling

The Regents of the University of California · Granted Jun 27, 2017 · Expires Jun 22, 2037

US 9663571

Oncostatin M receptor antigen binding proteins

Kiniksa Pharmaceuticals, GmbH · Granted May 30, 2017 · Expires May 25, 2037

US 9630931

Pharmaceutically active pyrazine derivatives

SENTINEL ONCOLOGY LIMITED · Granted Apr 25, 2017 · Expires Apr 20, 2037

US 9624228

Inhibitors of ERK and methods of use

Kura Oncology, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

US 9610309

Liquid viral formulations

ONCOLYTICS BIOTECH INC. · Granted Apr 4, 2017 · Expires Mar 30, 2037

US 9610352

Lyophilized viral formulations

ONCOLYTICS BIOTECH INC. · Granted Apr 4, 2017 · Expires Mar 30, 2037

US 9593163

Oncostatin M receptor antigen binding proteins

Kiniksa Pharmaceuticals, GmbH · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9586975

Macrocyclic salt-inducible kinase inhibitors

Oncodesign SA · Granted Mar 7, 2017 · Expires Mar 2, 2037

US 9572883

Oncolytic rhabdovirus

TURNSTONE LIMITED PARTNERSHIP · Granted Feb 21, 2017 · Expires Feb 16, 2037